Paola Argiento
Overview
Explore the profile of Paola Argiento including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gargani L, Pugliese N, De Biase N, Mazzola M, Agoston G, Arcopinto M, et al.
J Am Coll Cardiol
. 2023 Nov;
82(21):1973-1985.
PMID: 37968015
Background: Exercise echocardiography is used for assessment of pulmonary circulation and right ventricular function, but limits of normal and disease-specific changes remain insufficiently established. Objectives: The objective of this study...
12.
DAlto M, Liccardo B, Di Maio M, Del Giudice C, Romeo E, Argiento P, et al.
J Am Soc Echocardiogr
. 2023 Aug;
36(11):1181-1189.
PMID: 37544385
Objectives: The differential diagnosis between pulmonary arterial hypertension (PAH) and postcapillary pulmonary hypertension (PH) in heart failure with preserved ejection fraction (HFpEF) is sometimes difficult despite guidelines-derived standardized step-by-step diagnostic...
13.
Bassareo P, Argiento P, Mcmahon C, Dunne E, Walsh K, Russo M, et al.
Children (Basel)
. 2023 Mar;
10(3).
PMID: 36980076
Introduction: Paediatric pulmonary hypertension (PH) represents a heterogeneous illness that is responsible for high morbidity and mortality if left without treatment. Idiopathic pulmonary arterial hypertension (IPAH) is a subtype of...
14.
Badagliacca R, DAlto M, Ghio S, Argiento P, Brunetti N, Casu G, et al.
ERJ Open Res
. 2022 Nov;
8(4).
PMID: 36382240
Rationale: Demographic characteristics of pulmonary arterial hypertension (PAH) patients have changed over time, but the effects of cardiovascular risk factors on risk status and pulmonary vascular resistance (PVR) reduction with...
15.
Arena R, Ozemek C, Canada J, Lavie C, Borghi-Silva A, Bond S, et al.
Curr Probl Cardiol
. 2022 Sep;
48(1):101423.
PMID: 36167224
Cardiorespiratory fitness (CRF) has been proposed as a vital sign for the past several years, supported by a wealth of evidence demonstrating its significance as a predictor of health trajectory,...
16.
Benincasa G, Maron B, Affinito O, DAlto M, Franzese M, Argiento P, et al.
J Cardiovasc Transl Res
. 2022 Aug;
16(1):17-30.
PMID: 35960497
Pathogenic DNA methylation changes may be involved in pulmonary arterial hypertension (PAH) onset and its progression, but there is no data on potential associations with patient-derived hemodynamic parameters. The reduced...
17.
Vizza C, Ghio S, Badagliacca R, Manzi G, Scelsi L, Argiento P, et al.
Int J Cardiol
. 2022 Jun;
364:119-123.
PMID: 35716936
No abstract available.
18.
Badagliacca R, Papa S, DAlto M, Ghio S, Agostoni P, Ameri P, et al.
Eur Respir J
. 2022 Mar;
60(4).
PMID: 35301247
Objective: The coronavirus disease 2019 (COVID-19) outbreak has led to significant restrictions on routine medical care. We conducted a multicentre nationwide survey of patients with pulmonary arterial hypertension (PAH) to...
19.
DAlto M, Di Maio M, Romeo E, Argiento P, Blasi E, Vilio A, et al.
Eur Respir J
. 2022 Jan;
60(2).
PMID: 34996833
Background: According to current guidelines, the diagnosis of pulmonary hypertension (PH) relies on echocardiographic probability followed by right heart catheterisation (RHC). How echocardiography predicts PH recently redefined by mean pulmonary...
20.
DAlto M, Romeo E, Argiento P, Blasi E, Vilio A, Golino P
G Ital Cardiol (Rome)
. 2021 Sep;
22(10):844-850.
PMID: 34570118
The cause of dyspnea may remain uncertain even after a complete non-invasive clinical workup, and a right heart catheterization is performed to achieve a definitive diagnosis. Although pulmonary artery wedge...